Related Experiment Video
Updated: Dec 12, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Galactosialidosis Type IIb with Bilateral Macular Cherry-Red Spots but Mild Dysfunction
Hanon Fukuyo1, Yuji Inoue1, Hidenori Takahashi1
1Department of Ophthalmology, Jichi Medical University, Tochigi, Japan.
This case study highlights galactosialidosis, a rare metabolic disorder diagnosed via macular cherry-red spots. Ocular and systemic findings were mild, with genetic confirmation of CTSA gene mutations.
Area of Science:
- Genetics
- Ophthalmology
- Metabolic Disorders
Background:
- Galactosialidosis is a rare lysosomal storage disease caused by CTSA gene mutations.
- Ocular manifestations, particularly in type IIb, are not extensively documented.
- Early diagnosis is crucial for managing metabolic disorders.
Observation:
- A 35-year-old male presented with blurred vision and bilateral macular cherry-red spots.
- Ocular findings included corneal stromal deposits, lens opacity, and retinal changes on OCT.
- Mild systemic and neurological symptoms were noted.
Findings:
- Diagnosis of galactosialidosis confirmed by decreased beta-galactosidase and sialidase activity.
- Genetic analysis revealed abnormalities in protective proteins linked to the CTSA gene.
- Ophthalmological findings included hyperreflective retinal regions and thickened ganglion cell layers.
Implications:
- This case emphasizes the diagnostic significance of macular cherry-red spots in lysosomal storage diseases.
- Mild late-onset galactosialidosis may present with subtle ophthalmological findings.
- Long-term monitoring is essential for patients with mild galactosialidosis.
More Related Videos
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
06:16Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
Related Concept Videos
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism
Lysosomal Hydrolases
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Genetic Lingo
iPS Cell Differentiation